Salix Pharmaceuticals
Top View
- Jury Trial Demanded
- Faculty Disclosure
- Healthcare and Life Sciences Group
- 02/10/2015 Provider Subsystem Healthcare and Family Services Run Time: 20:51:09 Report Id 2794D051 Page: 01
- Medicaid System (Mmis) Illinois Department of Run Date: 02/10/2015 Provider Subsystem Healthcare and Family Services Run Time: 20:51:09 Report Id 2794D052 Page: 01
- View with the Wall Street Journal.1 Continues to Grow
- Biosimilars with Your IBD Patients? ▪ Very Comfortable ▪ Somewhat Comfortable ▪ Not at All Comfortable
- Manufacturers and Wholesalers Street City ST Zip Submitted Under
- 4Q2015 Active Labeler Labeler Company 00002 ELI LILLY and COMPANY 00003 E.R
- Salix Pharmaceuticals | Gastroenterology | 2008 Annual Report
- Faculty Disclosure
- RS PDF Biotech Data
- List of Issuers with No Outstanding Past-Due Share of the Issuer Accounting Support Fee
- 2011 Annual Report
- 2794D052alphalist May 2015.Xlsx
- Valeant, the Serial Pharma Dealmaker Cuts Again
- Rebateable Manufacturers
- Long-Term Efficacy of Vedolizumab for Crohn's Disease